Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?"

Transcription

1 Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?

2 Introduc2on

3 EU Medical Device Overview

4 Current Medical Device Direc2ves ü Governed by 3 directives (past yrs):

5 Polling Ques2on #1

6 Current Medical Device Direc2ves ü US > FDA oversees all pharmaceuticals and medical devices ü EU > European Medicines Agency (EMA) for pharmaceuticals and Conformité Européenne (CE) marking for devices No centralized agency responsible for issuing CE marking Such marking not an authorization to sell a product Requirements for CE marking based on risk ü Notified Bodies standards vary; in general, relatively little data needed to obtain CE marking ü May 2011, EUDAMED established to share data regarding device certifications, clinical investigations, and safety surveillance; at present, EUDAMED not accessible to device manufacturers, healthcare providers, or the public

7 Need for Updated Direc2ves ü Current system for certification has 2 main strengths: Streamlined processes: Little difference between US and EU serious recalls: ü However, EU system criticized for inconsistencies in interpretation and in standards between Notified Bodies Several high-profile recalls of medical devices in the last few years Both the European Council and European Parliament have issued statements regarding need to update medical device directives to meet the needs of tomorrow and achieve a suitable, robust, transparent and sustainable regulatory framework

8 Need for Updated Direc2ves ü To that end, the European Commission has identified seven problems that should be addressed in any new legislation: Oversight of Notified Bodies Post-market safety Regulatory status of products Lack of transparency and harmonized traceability Access to external expertise Unclear and insufficient obligations and responsibilities of economic operators Management of the regulatory system

9 Polling Ques2on #2

10 Proposed Legisla2on ü September 2012, European Commission proposed legislation to modernize & expand medical device directives and update them to regulations ü Two separate but related documents: One covers medical devices and active implantable medical devices (combination of the current MDD and AIMDD directives) Another addresses in vitro diagnostic medical devices (similar to the current IVDD directive) For both directives, stated objectives are to: Ensure a high level of protection of human health and safety Ensure the smooth functioning of the internal [EU] market Provide a regulatory framework that is supportive of innovation and the competitiveness of the European medical device industry

11 Proposed Legisla2on

12 Parliamentary Review ü Proposed legislation under review; both regulations routed to the Committee on the Environment, Public Health, and Food Safety, but were assigned to different rapporteurs:

13 Looking to the Future ü Rapporteur reports released in April 2013, still in draft form, overall tone of the opinions unlikely to change ü Minor modifications required to in vitro diagnostic device directive; however, forward movement likely to be stopped until question of centralized device authority resolved ü Eucomed supports Commission s proposal to strengthen current Notified Bodies Stated that only the best Notified Bodies should be allowed to approve medical devices But, they ve expressed concern that switching to centralized system would drastically increase time it takes to get device to market in EU

14 Looking to the Future

15 Looking to the Future ü Are concerns well-founded? Amount of data likely to be required on higher-risk medical devices Conducting additional research does require time and money, although there does not appear to be an expectation for pharmaceutical-style trials involving large numbers of patients Concerns about delays during the review and approval process may be more difficult to substantiate if the approving bodies establish (and adhere to) fixed timelines If the EMA can review a new drug application in 270 days, then presumably any medical device could be adequately vetted in the same time period

16 What s Next? ü Commission estimated regulations would be adopted in 2014 and gradually implemented between 2015 and 2019 ü Device development programs nearing completion in 2013 should be able to proceed unhindered ü Sponsors in the early to middle stages of development would be wise to incorporate the proposed legislation into their planning process While implementation and oversight processes of the draft medical device regulations may vary, fundamental aspects are unlikely to change significantly Small to mid-sized sponsors, particularly those without an established presence in Europe, may benefit from partnering with company that has a seasoned regulatory strategy group and a team on-the-ground

17 Ques2ons?

The Medical Device Coordination Group: a new Authority Under EU Device Regulations

The Medical Device Coordination Group: a new Authority Under EU Device Regulations The Medical Device Coordination Group: a new Authority Under EU Device Regulations By Robert D. Cumming and Nancy W. Mathewson, Esq. This article discusses the organization and functions of the Medical

More information

The implications of the new EU Medical Device Regulation on Combination Product Packaging

The implications of the new EU Medical Device Regulation on Combination Product Packaging The implications of the new EU Medical Device Regulation on Combination Product Packaging ANDREW LOVE VP Capability Development Be4ward Ltd Introduction Be4ward Andrew Love www.andrewrlove.com A niche

More information

The implications of the new EU Medical Device Regulation on Combination Product Packaging

The implications of the new EU Medical Device Regulation on Combination Product Packaging The implications of the new EU Medical Device Regulation on Combination Product Packaging June 2017 ANDREW LOVE VP Capability Development Be4ward Ltd Introduction Be4ward Andrew Love www.andrewrlove.com

More information

Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules

Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction

More information

Recast Medical Device directives Impacts on materiovigilance

Recast Medical Device directives Impacts on materiovigilance Recast Medical Device directives Impacts on materiovigilance Journée Vigilance 23.03.2017 Valérie Nys Revision of the EU Medical Devices Legislation Directive 90/385/EEC on active implantable medical devices

More information

Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations

Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Paul Brooks Vice President Healthcare, Americas Presentation to:

More information

International Standards and EU regulation of medical device software an update

International Standards and EU regulation of medical device software an update International Standards and EU regulation of medical device software an update Sherman Eagles Partner, SoftwareCPR seagles@softwarecpr.com 612 865 0107 1 Who am I? 18 years at Medtronic, retired 2008 Last

More information

Medical Device Regulation Overview

Medical Device Regulation Overview Medical Device Regulation Overview Dr Haidong Liang, PhD Clifton Medtech Consulting info@cliftonmedtech.com http://cliftonmedtech.com/ What is the issue? Existing EU Directives dating back to the 1990s

More information

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day GS1 Ireland Healthcare User Group (HUG) Information Day Regulatory update Medical Devices and the impact for Irish Healthcare Sinead Duggan, HPRA 28 th March 2017 29/03/2017 2 Medical Devices Regulation

More information

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part

More information

Developing a European First-in-Human Study: Three Key Decisions

Developing a European First-in-Human Study: Three Key Decisions Developing a European First-in-Human Study: Three Key Decisions By Nicole Feist, BA Clinical A key step in the translational medicine benchtop to bedside process model is the move from research and preclinical

More information

IVD Regulation 2017/746

IVD Regulation 2017/746 IVD Regulation 2017/746 Dr. Anne Van Nerom Famhp 2017-06-13 Recast-symposium Auditorium Storck (Eurostation II) Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32 2 642 51 11 F +32 2 642 50 01 email:

More information

Ready or Not: The New Medical Device Regulations Are Here!

Ready or Not: The New Medical Device Regulations Are Here! Ready or Not: The New Medical Device Regulations Are Here! Felicia R Cochran, PhD, CMPP TM feliciacochran@earthlink.net FR Cochran 1 General Disclaimers This presentation represents the knowledge, professional

More information

U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE

U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE Jeff Shuren Director Center for Devices and Radiological Health CDRH STRATEGIC PRIORITIES UPDATE The Center for Devices and Radiological Health

More information

MEDICAL DEVICE. Technical file.

MEDICAL DEVICE. Technical file. MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing

More information

Post market Surveillance ISO EU Medical Device Regulation

Post market Surveillance ISO EU Medical Device Regulation Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes

More information

Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland

Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland AUT-G0095-1 15 AUGUST 2014 This guide does not purport to be an interpretation of law and/or regulations and is for

More information

Roles and responsibilities of members and alternates, rapporteur and peer reviewers, experts and observers of the Paediatric Committee (PDCO)

Roles and responsibilities of members and alternates, rapporteur and peer reviewers, experts and observers of the Paediatric Committee (PDCO) Last revision: 16 September 2010 EMA/537415/2008 Human Medicines Development and Evaluation Roles and responsibilities of members and alternates, rapporteur and peer reviewers, experts and observers of

More information

The New EU IVDR. Overview of the Main Changes & Clinical Data Requirements. Advance Regulatory Consulting Ltd.

The New EU IVDR. Overview of the Main Changes & Clinical Data Requirements. Advance Regulatory Consulting Ltd. Overview of the Main Changes & Clinical Data Requirements Advance Regulatory Consulting Ltd. : Timeline: Entry in to force Q2 (Apr) 2017 Adoption: +6m NB s apply for designation IVDs classified as Class

More information

arena that impact on clinical development

arena that impact on clinical development RESEARCH DEVELOPMENT Changes in the regulatory arena that impact on clinical development 23 May 2011 Agenda Voluntary Harmonisation Procedure PIP and Paediatric requirements Changes to EudraCT and European

More information

Due diligence in the European medical devices industry

Due diligence in the European medical devices industry Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's

More information

Unique Device Identification

Unique Device Identification Unique Device Identification The State of Play in Europe Andrew Rutter, Regulatory Affairs Manager, Ortho-Clinical Diagnostics 22 October 2015 Ortho-Clinical Diagnostics Headquartered in Raritan, NJ, USA

More information

Questions And Answers To Support The

Questions And Answers To Support The Questions And Answers To Support The Implementation Of The Pharmacovigilance Legislation - Update This Question and answers section gives advice on regulatory issues in on the interpretation and implementation

More information

Guide to field safety corrective actions for medical devices and in-vitro diagnostic medical devices

Guide to field safety corrective actions for medical devices and in-vitro diagnostic medical devices Guide to field safety corrective actions for medical devices and in-vitro diagnostic medical devices Item type Authors Publisher Report Irish Medicines Board (IMB) Irish Medicines Board (IMB) Downloaded

More information

UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS

UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS Executive Summary European Medicines Agency (EMA) regulations for licensing of medical devices include the use of authorized

More information

Chin Koerner Executive Director US Regulatory and Development Policy

Chin Koerner Executive Director US Regulatory and Development Policy Chin Koerner Executive Director US Regulatory and Development Policy Novartis Pharmaceuticals Corporation 1700 Rockville Pike Suite 510 Rockville, MD 20852 Tel 301.468.5607 Fax 301.468.5614 Email: Chin.Koerner@novartis.com

More information

Recent developments in Pharmacovigilance from the Regulator s Perspective. In strategy, competence, quality and flexibility

Recent developments in Pharmacovigilance from the Regulator s Perspective. In strategy, competence, quality and flexibility Recent developments in Pharmacovigilance from the Regulator s Perspective In strategy, competence, quality and flexibility Pharmacovigilance Regulatory Affairs Operations Medical Writing & toxicology Recent

More information

Your complimentary Clinica Medtech Intelligence content

Your complimentary Clinica Medtech Intelligence content Your complimentary Clinica Medtech Intelligence content Clinica provides you with up to the minute coverage and opinion on company, product, market and regulatory developments as well as market size, growth

More information

Dangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level. David Barton

Dangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level. David Barton Dangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level David Barton Department of Clinical Genetics Our Lady s Children s Hospital Dublin Background Diagnostic tests, known as

More information

Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior

Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Regulatory and Compliance Counsel, BioTeknica Panelists:

More information

Update on Recast of IVD Directive

Update on Recast of IVD Directive Update on Recast of IVD Directive www.pei.de IVD Classification In-house Assays EU Reference Laboratories C M Nübling, PEI Concerns identified by the European Commission in the Medical Devices Roadmap

More information

EU MDR Timeline. Dr. Christian B. Fulda Jones Day FDLI Annual Conference Access materials at fdli.org/annual2018

EU MDR Timeline. Dr. Christian B. Fulda Jones Day FDLI Annual Conference Access materials at fdli.org/annual2018 EU MDR Timeline Dr. Christian B. Fulda Jones Day EU MDR - Timeline EU has entered into force, but will only apply for products as of May 26, 2020, with transitional period through 2024/2025? Look closer!

More information

EU Clinical Trial Regulation A view from the Industry

EU Clinical Trial Regulation A view from the Industry Conference EU Clinical Trial Regulation EU Clinical Trial Regulation A view from the Industry Judith Creba, Executive Director, EU Regulatory Strategy, Novartis Pharma AG University of Basel, Law Faculty

More information

New EU Regulation on medical devices

New EU Regulation on medical devices New EU Regulation on medical devices Summary of key changes and challenges for implementation Adrian Bartlett Medical Devices, EU Policy Manager Nickie Colson Policy Advisor, EU & International Team Content

More information

Review of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels

Review of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Review of EU Clinical Trial Directive 15

More information

VIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE

VIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE VIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE VIGILANZA E SORVEGLIANZA POST-COMMERCIALIZZAZIONE Post-Market Surveillance dal punto di vista dell O.N in vista dei nuovi Regolamenti (MDR/IVDR) Francesco

More information

The new EU Regulations on medical devices and first steps of their implementation

The new EU Regulations on medical devices and first steps of their implementation The new EU Regulations on medical devices and first steps of their implementation TOPRA Annual Medical Devices Symposium 2017 London, 3 October 2017 Erik HANSSON Deputy Head of Unit Health Technology and

More information

GETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR)

GETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR) GETTING READY FOR THE EUROPEAN UNION (EU) MEDICAL DEVICE REGULATION (MDR) Caroline Leab Abbott Director of Regulatory Affairs David Wolf PTC Program Director of Medical Device Strategy liveworx.com NEW

More information

New Pharmacovigilance legislation. Post-authorisation safety studies. ENCePP Plenary meeting. 3 May 2012

New Pharmacovigilance legislation. Post-authorisation safety studies. ENCePP Plenary meeting. 3 May 2012 New Pharmacovigilance legislation Post-authorisation safety studies ENCePP Plenary meeting 3 May 2012 Presented by: Annalisa Rubino, PhV and Risk Management, EMA An agency of the European Union Why? Public

More information

How to Get ISO Certified

How to Get ISO Certified People frequently ask me where to locate information about ISO 13485, so this whitepaper was written specifically to address their needs, as well as review in detail the six steps to preparing for ISO

More information

Top 10. Changing Enforcement Environment. The Fourth Annual Medical Device Regulatory, Reimbursement and Compliance Congress November 10, 2009

Top 10. Changing Enforcement Environment. The Fourth Annual Medical Device Regulatory, Reimbursement and Compliance Congress November 10, 2009 The Fourth Annual Medical Device Regulatory, Reimbursement and Compliance Congress November 10, 2009 Roundtable on the Top 10 Device Manufacturer-FDA Regulatory Issues Dorothy J. Clarke, Esq., Vice President,

More information

Changes to the Medical Devices Directive and affect on Manufacturers

Changes to the Medical Devices Directive and affect on Manufacturers TÜV Product Service Ltd Webinar 18 th November 2009 Changes to the Medical Devices Directive and affect on Manufacturers Henry Sibun Manager, Medical & Health Services UK CONTENTS / 1. Introduction 1.

More information

Update on the IVDR. Sue Spencer

Update on the IVDR. Sue Spencer Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application

More information

Medical Devices. LATVIA LAWIN Klavins & Slaidins

Medical Devices. LATVIA LAWIN Klavins & Slaidins Medical Devices LATVIA LAWIN Klavins & Slaidins CONTACT INFORMATION Sarmis Spilbergs LAWIN Klavins & Slaidins Elizabetes 15, Riga, LV 1010, Latvia +371 67814848 sarmis.spilbergs@lawin.lv www.lawin.com

More information

ABPI response to European Commission consultation on advanced therapy medicinal products

ABPI response to European Commission consultation on advanced therapy medicinal products ABPI response to European Commission consultation on advanced therapy medicinal products 28 March 2013 ABPI response to European Commission consultation on the regulation of advanced therapy medicinal

More information

The EU s In Vitro Diagnostics (IVD) Regulation:

The EU s In Vitro Diagnostics (IVD) Regulation: The EU s In Vitro Diagnostics (IVD) Regulation: a summary of the regulatory requirements for software and genetic tests The European Union (EU) s In Vitro Diagnostics (IVD) Regulation (of 5 April 2017)

More information

Regulatory Requirements

Regulatory Requirements Regulatory Requirements CTTI Quality by Design Workshop 28-29 Jan 2013 Rockville, MD Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency An agency of the European Union Disclaimer

More information

Conformity Assessment of Own Brand Labelling

Conformity Assessment of Own Brand Labelling NBRG/306/06 Co-ordination of Title: Chapter: Conformity Assessment of Own Brand Labelling 2.5.5 Conformity assessment for particular product groups Text: Key words: manufacturer means the natural or legal

More information

Health Industry Alert

Health Industry Alert Health Industry Alert August 4, 2017 Senate Passes Long-Awaited FDA User Fee Package Following nearly two years of negotiations and hearings examining the Generic Drug User Fee Amendments (GDUFA) and the

More information

Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety

Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety Disclaimer The views and opinions expressed in this presentation are solely those of the presenter and do not necessarily reflect those of Vifor,

More information

Pharmacovigilance. An agency of the European Union

Pharmacovigilance. An agency of the European Union Pharmacovigilance An agency of the European Union Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse reactions and other medicine-related

More information

Pharmabiotics: a Regulatory Hurdle in Europe

Pharmabiotics: a Regulatory Hurdle in Europe Pharmabiotics: a Regulatory Hurdle in Europe Dr. Magali Cordaillat-Simmons PRI Executive Scientist Raleigh, NC, USA September 8th, 2014 PHARMABIOTICS: A REGULATORY HURDLE IN EUROPE I. Introduction to Pharmabiotics

More information

Medicines Control Council & update on SA Health Products Regulatory Authority

Medicines Control Council & update on SA Health Products Regulatory Authority Medicines Control Council & update on SA Health Products Regulatory Authority South African Pharmaceutical Regulatory Affairs Association (SAPRAA) 08 April 2016 Outline Introduction Policy & Legislative

More information

Adverse Event Reporting

Adverse Event Reporting Adverse Event Reporting AE Case Receipt When we receive a case, we induct it through a well-oiled process that reduces the number of subsequent queries, classifies events appropriately, and increases the

More information

EMA perspective on increasing focus on review of device components of medicinal products

EMA perspective on increasing focus on review of device components of medicinal products EMA perspective on increasing focus on review of device components of medicinal products TOPRA Annual Human Medicines Symposium 2 4 October 2017 - Victoria Park Plaza Hotel, London Presented by Armin Ritzhaupt,

More information

Clinical Trial Transparency UK perspective

Clinical Trial Transparency UK perspective Clinical Trial Transparency UK perspective Dr Bina Rawal Medical, Innovation & Research Director Association of the British Pharmaceutical Industry January 2014 1 Outline Transparency timeline Campaign

More information

NEW EU Regulations and the EU UDI system

NEW EU Regulations and the EU UDI system NEW EU Regulations and the EU UDI system 24 October 2017, Brussels Géraldine Lissalde-Bonnet Director Public Policy, GS1 Global Office Disclaimer Neither GS1 nor its member organizations nor their staffs

More information

A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation

A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation A Risk-based Approach for In Vitro Companion Diagnostics

More information

Report from the Paediatric Committee on its first anniversary

Report from the Paediatric Committee on its first anniversary European Medicines Agency London, 11 July 2008 Doc. Ref. EMEA/PDCO/347884/2008 Report from the Paediatric Committee on its first anniversary The European Medicines Agency s Paediatric Committee (PDCO)

More information

The interface between Good Clinical Practice and Good Manufacturing Practice

The interface between Good Clinical Practice and Good Manufacturing Practice 1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who

More information

EU Regulation Review: challenges and opportunities for industry

EU Regulation Review: challenges and opportunities for industry EU Regulation Review: challenges and opportunities for industry Mia Bengtström, Pharma Industry Finland Nordic Pediatric Conference June 13,2017 Paediatric Regulation Consultation: EFPIA s answers general

More information

Importance of Pharmacovigilance for Pharmaceutical Industry

Importance of Pharmacovigilance for Pharmaceutical Industry Importance of Pharmacovigilance for Pharmaceutical Industry JARIR AT THOBARI, MD, DPHARM, PHD FACULTY OF MEDICINE GADJAH MADA UNIVERSITY YOGYAKARTA, INDONESIA Role of Pharma Company Globally Investment

More information

11% of employees are dedicated to R&D. 11 billions IVD market size 3,000 companies 75,000 people employed. 40,000 IVD products

11% of employees are dedicated to R&D. 11 billions IVD market size 3,000 companies 75,000 people employed. 40,000 IVD products About edma EDMA The European Diagnostic Manufacturers Association is an international, non-profit organisation representing the interests of the European in vitro diagnostics industry at the European and

More information

White Paper: Improvements to the Australian Regulatory System for Medical Devices. 23 May 2014

White Paper: Improvements to the Australian Regulatory System for Medical Devices. 23 May 2014 White Paper: Improvements to the Australian Regulatory System for Medical Devices 23 May 2014 mtaa.org.au Medical technology for a healthier Australia 0 www.mtaa.org.au Level 12, 54 Miller St, North Sydney

More information

Medical Device Directive

Medical Device Directive Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,

More information

Committees/Working Groups contributing to the implementation of the Medical Device Directives

Committees/Working Groups contributing to the implementation of the Medical Device Directives EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE GENERAL Consumer Goods Cosmetics and Medical Devices MEDDEV. 2.15 Rev.3 December 2008 GUIDELINES ON MEDICAL DEVICES Committees/Working Groups contributing

More information

GS1 Guide on Unique Device Identification (UDI) implementation

GS1 Guide on Unique Device Identification (UDI) implementation GS1 Guide on Unique Device Identification (UDI) implementation This document aims at providing clarification to questions raised by the industry as well as implementation guidance on the use of GS1 standards.

More information

Guide for Ethics Committees on Clinical Investigation of Medical Devices

Guide for Ethics Committees on Clinical Investigation of Medical Devices Guide for Ethics Committees on Clinical Investigation of Medical Devices AUT-G0044-2 04 JUNE 2010 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes

More information

What are the regula+ons rela+ng to data disclosure to pa+ents? Current and future perspec+ves

What are the regula+ons rela+ng to data disclosure to pa+ents? Current and future perspec+ves What are the regula+ons rela+ng to data disclosure to pa+ents? Current and future perspec+ves Paul Woods Paul Woods Compliance Ltd pwcompliance@btinternet.com What MUST be shared What SHOULD be shared

More information

The challenges of software medical device regulation.

The challenges of software medical device regulation. The challenges of software medical device regulation. david.grainger@mhra.gov.uk Introduction A brief history of software device regulation A look at the new device regulations 2 Current framework In Vitro

More information

Guide to Scientific and Regulatory Advice for GXP activities

Guide to Scientific and Regulatory Advice for GXP activities Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction As precision

More information

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients

More information

The European Commission's Proposal to Re-design Existing European Drug Safety Rules. An Industry View on Practical Implications

The European Commission's Proposal to Re-design Existing European Drug Safety Rules. An Industry View on Practical Implications The European Commission's Proposal to Re-design Existing European Drug Safety Rules An Industry View on Practical Implications Margaret Walters Merck, Sharp & Dohme Ltd. The Second International Pharmaceutical

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 1 2 3 19 June 2012 EMA/119871/2012 4 5 Guideline on good pharmacovigilance practices (GVP) Module III Pharmacovigilance inspections Draft finalised by the Agency in collaboration with Member States and

More information

UDI (Unique Device Identification) and patient safety latest regulatory developments

UDI (Unique Device Identification) and patient safety latest regulatory developments UDI (Unique Device Identification) and patient safety latest regulatory developments Ulrike Kreysa, VP Healthcare, GS1 Global Office Medical Devices Innovation Program Munich, 14 October 2016 Agenda UDI

More information

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no: Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved

More information

Section I: Pharmaceuticals and Medical Devices

Section I: Pharmaceuticals and Medical Devices SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical

More information

An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies. SPEAKER: Suzanne Murray Biogen

An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies. SPEAKER: Suzanne Murray Biogen An Industry Perspective: The Complexity of Postapproval CMC Changes and Proposed Regulatory Strategies SPEAKER: Suzanne Murray Biogen Contents 1. BioPhorum Operations Group (BPOG) and the Post-approvals

More information

This video gives an overview of the centralised procedure at the European Medicines Agency

This video gives an overview of the centralised procedure at the European Medicines Agency This video gives an overview of the centralised procedure at the European Medicines Agency In Europe today, all medicines must have a marketing authorisation before they can be used by patients And there

More information

PHARMA CONGRESS. Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments. October 28, 2008

PHARMA CONGRESS. Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments. October 28, 2008 PHARMA CONGRESS October 28, 2008 Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments Beverly H. Lorell, MD Senior Medical & Policy Advisor King & Spalding LLP Assessing

More information

European Commission s strategy for single market Using Bolar and the SPC Wavier to Stimulate Growth in the EU

European Commission s strategy for single market Using Bolar and the SPC Wavier to Stimulate Growth in the EU European Commission s strategy for single market Using Bolar and the SPC Wavier to Stimulate Growth in the EU Ravinder Chahil Director of Intellectual Property Polpharma Group SA 8 March 2016 Content Commission

More information

Pharmamarketing - strategic challenges

Pharmamarketing - strategic challenges Pharmamarketing - strategic challenges Biomedicine Master Program Lund University Course: Biomedicine the Profession Anna Chérouvrier Hansson, MSc. December 16th, 2014 1. Pharmamarketing - definitions

More information

Role Profile Acting Pharmacovigilance Compliance Assessor, Pharmacovigilance Human Products Monitoring

Role Profile Acting Pharmacovigilance Compliance Assessor, Pharmacovigilance Human Products Monitoring Role Profile Acting Pharmacovigilance Compliance Assessor, Pharmacovigilance Human Products Monitoring ROLE SUMMARY Reporting to the Pharmacovigilance (PV) Manager the Acting Pharmacovigilance Compliance

More information

Pharmacovigilance- Content of the New EU Legislation and Challenges for BfArM

Pharmacovigilance- Content of the New EU Legislation and Challenges for BfArM Pharmacovigilance- Content of the New EU Legislation and Challenges for BfArM 12 th DGRA Annual Congress June 15 to 16, Bonn U. Hagemann Bundesinstitut für Arzneimittel und Medizinprodukte BfArM Visit

More information

Pharmacovigilance System Master file

Pharmacovigilance System Master file IMPLEMENTING MEASURES IN ORDER TO HARMONISE THE PERFORMANCE OF THE PHARMACOVIGILANCE ACTIVITIES PROVIDED FOR IN DIRECTIVE 2001/83/EC AND REGULATION (EC) NO 726/2004 Pharmacovigilance System Master file

More information

Post Market Surveillance (including PMCF): common non compliances

Post Market Surveillance (including PMCF): common non compliances Post Market Surveillance (including PMCF): common non compliances Jayanth Katta Ph.D Product Specialist & Certification Manager, General Devices Team, Healthcare 1 Overview EU PMS Requirements for Medical

More information

EUnetHTA. European network for Health Technology Assessment. European network for Health Technology Assessment JA

EUnetHTA. European network for Health Technology Assessment. European network for Health Technology Assessment JA EUnetHTA European network for Health Technology Assessment Outline The Making of EUnetHTA EUnetHTA and the HTA Network EUnetHTA Achievements and Tools General Information about HTA 2 The Making of EUnetHTA

More information

By: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS

By: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS AN INTRODUCTION TO THE WORLDWIDE REGULATORY FRAMEWORK FOR MEDICAL DEVICES By: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS COURSE OUTLINE /

More information

COCIR SUSTAINABLE COMPETENCE IN ADVANCING HEALTHCARE

COCIR SUSTAINABLE COMPETENCE IN ADVANCING HEALTHCARE IMPLEMENTING MEDICAL DEVICE REGULATION COCIR VIEWS ON THE WAY FORWARD COCIR SUSTAINABLE COMPETENCE IN ADVANCING HEALTHCARE European Coordination Committee of the Radiological, Electromedical and Healthcare

More information

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials

More information

Regulatory and ethical requirements in medical device studies. Finland

Regulatory and ethical requirements in medical device studies. Finland Regulatory and ethical in medical device studies Finland SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within

More information

POSITION PAPER Moving from the MDD to the MDR

POSITION PAPER Moving from the MDD to the MDR A summary of Key Changes regarding Sterile Packaging and considerations on recommended changes to standards Introduction EN ISO 11607 specifies the requirements and test methods for materials, preformed

More information

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the

More information

House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data

House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research

More information

Compliance mechanisms available in Russia to ensure adherence to ethical guidelines

Compliance mechanisms available in Russia to ensure adherence to ethical guidelines Compliance mechanisms available in Russia to ensure adherence to ethical guidelines Prof. Olga Kubar, Saint Petersburg Pasteur Institute, Russia 1 Project full title: Project acronym: Type of funding scheme:

More information

Clinical Evaluation and Clinical Investigation update MDR

Clinical Evaluation and Clinical Investigation update MDR Clinical Evaluation and Clinical Investigation update MDR December 5 th, 2017 Carine Cochereau, Cardinal Health Slide 1 Directives: obligation for Member State (MS) to implement provisions into their national

More information

INDUSTRY S VIEW ON THE FUTURE OF IN VITRO DIAGNOSTIC (IVD) LEGISLATION IN EUROPE. May 2013 SPECIAL REPRINT. By Jesús Rueda Rodríguez, EDMA

INDUSTRY S VIEW ON THE FUTURE OF IN VITRO DIAGNOSTIC (IVD) LEGISLATION IN EUROPE. May 2013 SPECIAL REPRINT. By Jesús Rueda Rodríguez, EDMA May 2013 SPECIAL REPRINT INDUSTRY S VIEW ON THE FUTURE OF IN VITRO DIAGNOSTIC (IVD) LEGISLATION IN EUROPE By Jesús Rueda Rodríguez, EDMA Reproduced with the kind permission of Global Regulatory Press from

More information

Software Regulation: The Transfusion Medicine Experience

Software Regulation: The Transfusion Medicine Experience AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin

More information